AR193536A1 - Procedimiento para la preparacion de compuestos de pirazolo(1,5a)pirimidina - Google Patents

Procedimiento para la preparacion de compuestos de pirazolo(1,5a)pirimidina

Info

Publication number
AR193536A1
AR193536A1 AR243489A AR24348972A AR193536A1 AR 193536 A1 AR193536 A1 AR 193536A1 AR 243489 A AR243489 A AR 243489A AR 24348972 A AR24348972 A AR 24348972A AR 193536 A1 AR193536 A1 AR 193536A1
Authority
AR
Argentina
Prior art keywords
pyrazolo
procedure
preparation
pyrimidine compounds
pyrimidine
Prior art date
Application number
AR243489A
Other languages
English (en)
Spanish (es)
Original Assignee
Int Chem & Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Chem & Nuclear Corp filed Critical Int Chem & Nuclear Corp
Application granted granted Critical
Publication of AR193536A1 publication Critical patent/AR193536A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR243489A 1971-08-16 1972-08-08 Procedimiento para la preparacion de compuestos de pirazolo(1,5a)pirimidina AR193536A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17219571A 1971-08-16 1971-08-16
US261103A US3920652A (en) 1971-08-16 1972-06-08 Aromatic substituted pyrazola {8 1,5a{9 {0 pyrimidine compounds useful as xanthine oxidase inhibitors

Publications (1)

Publication Number Publication Date
AR193536A1 true AR193536A1 (es) 1973-04-30

Family

ID=26867834

Family Applications (1)

Application Number Title Priority Date Filing Date
AR243489A AR193536A1 (es) 1971-08-16 1972-08-08 Procedimiento para la preparacion de compuestos de pirazolo(1,5a)pirimidina

Country Status (19)

Country Link
US (1) US3920652A (en:Method)
JP (1) JPS4834899A (en:Method)
AR (1) AR193536A1 (en:Method)
AT (1) AT330780B (en:Method)
BE (1) BE786611A (en:Method)
BG (1) BG19806A3 (en:Method)
DD (1) DD99581A5 (en:Method)
DE (1) DE2236987A1 (en:Method)
ES (1) ES405663A1 (en:Method)
FR (1) FR2150771B1 (en:Method)
GB (1) GB1359563A (en:Method)
HU (1) HU167466B (en:Method)
IE (1) IE36629B1 (en:Method)
IL (1) IL39988A0 (en:Method)
LU (1) LU65892A1 (en:Method)
MC (1) MC937A1 (en:Method)
NL (1) NL7211011A (en:Method)
RO (1) RO63871A (en:Method)
SU (1) SU522800A3 (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093617A (en) * 1974-11-12 1978-06-06 Icn Pharmaceuticals, Inc. 3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
US4048184A (en) * 1976-11-15 1977-09-13 E. R. Squibb & Sons, Inc. 6-Phenyl-2H-pyrazolo[3,4-b]pyridines
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
WO1992006096A1 (fr) * 1990-10-09 1992-04-16 Otsuka Pharmaceutical Co., Ltd. Derive de pyrimidine, production de ce derive et inhibiteur d'androgenes
AU667575B2 (en) * 1992-10-20 1996-03-28 Otsuka Pharmaceutical Co., Ltd. Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
KR100260292B1 (ko) * 1995-09-28 2000-07-01 오쓰카 요시미쓰 진통제
US6664261B2 (en) 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
ES2294800T3 (es) * 1996-07-24 2008-04-01 Bristol-Myers Squibb Pharma Company Azolo triazinas y pirimidinas.
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6235741B1 (en) * 1997-05-30 2001-05-22 Merck & Co., Inc. Angiogenesis inhibitors
WO1999024038A1 (en) * 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
US6380203B1 (en) * 1998-01-14 2002-04-30 Merck & Co., Inc. Angiogenesis inhibitors
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
WO2000059908A2 (en) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
WO2015186117A1 (en) 2014-06-06 2015-12-10 Siemens Medical Solutions Usa, Inc. Gamma camera dead time determination in real time using long lived radioisotopes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048587A (en) * 1960-10-17 1962-08-07 Ortho Pharma Corp 2-alkylamino-4-aminopyrimidine
US3296268A (en) * 1965-10-19 1967-01-03 Searle & Co 3-cyanoethyl-2-oxo-5-phenyl [1, 5-a] pyrimidines

Also Published As

Publication number Publication date
US3920652A (en) 1975-11-18
RO63871A (fr) 1979-01-15
BE786611A (fr) 1973-01-22
IL39988A0 (en) 1972-09-28
SU522800A3 (ru) 1976-07-25
GB1359563A (en) 1974-07-10
ATA677372A (de) 1975-10-15
IE36629L (en) 1973-02-16
NL7211011A (en:Method) 1973-02-20
FR2150771A1 (en:Method) 1973-04-13
BG19806A3 (bg) 1975-10-10
IE36629B1 (en) 1977-01-19
AT330780B (de) 1976-07-26
MC937A1 (fr) 1973-08-10
DE2236987A1 (de) 1973-03-01
DD99581A5 (en:Method) 1973-08-12
HU167466B (en:Method) 1975-10-28
ES405663A1 (es) 1976-01-16
FR2150771B1 (en:Method) 1976-05-21
LU65892A1 (en:Method) 1973-01-15
JPS4834899A (en:Method) 1973-05-22

Similar Documents

Publication Publication Date Title
AR193536A1 (es) Procedimiento para la preparacion de compuestos de pirazolo(1,5a)pirimidina
AR194587A1 (es) Procedimiento para la preparacion de 2,2'metilendifenoles sustituidos
AR194298A1 (es) Procedimiento para la preparacion de derivados de 1,2,4-triazoles sustituidos
AR193624A1 (es) Procedimiento para la preparacion de compuestos de 8-oxo-5-tia-1-azabiciclo(4,2,0)oct-2-eno
AR204981A1 (es) Procedimiento para la elaboracion de 1,4,5,6-tetrahidro-piridinas 3-substituidas
AR199879A1 (es) Procedimiento para la elaboracion de 4-aza-benzimidazoles
AR192347A1 (es) Procedimiento para la preparacion de 3-amino-imidazo(1,5-a)piridinas
AR208393A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
AR204899A1 (es) Procedimiento para la preparacion de 3-carbamoiloximetilcefalosporinas
FI55845C (fi) Foerfarande foer framstaellning av en 8-d-ribityl-pyrido(2,3-d)pyrimidin
AR203017A1 (es) Procedimiento para la preparacion de fenilimidazolidinonas
AR196759A1 (es) Procedimiento para la produccion de compuestos, de quinazolina 2,4-diamino- 6 - substitudos (05,6-disubstituidos)
SE380804B (sv) Anologiforfarande for framstellning av s-triazolo (1,5-a) (1,4)
AR193078A1 (es) Metodo para la preparacion de 2,4-diamino-bencilpirimidinas
AR197762A1 (es) Procedimiento para la preparacion de 3-carbetoxihidrazinopiridazinas 6-sustituidas
AR192245A1 (es) Procedimiento para la preparacion de pirimidinas 2,5-disubstituidas
AR193162A1 (es) Procedimiento para la preparacion de compuestos de aminoalcanamidas 2,2-disubstituidas
AR205784A1 (es) Procedimiento para la elaboracion de penicilamina
AR192655A1 (es) Procedimiento para la preparacion de derivados de benzodiacepina
AR192730A1 (es) Procedimiento para la preparacion de 3-ciclopentileter de 7a-metil-3,16a,17-trihidroxi-delta1,3,5(10)-estratrienos
AR193576A1 (es) Procedimiento para la preparacion de pirimidotriacinas
AR192485A1 (es) Procedimiento para la preparacion de biguanidas 1,2-substituidas
AR194257A1 (es) Procedimiento para la preparacion de 3beta-hidroxi-14,15beta-epoxi-5-beta-cardenoli-o 5-beta-bufadienolid-glicosidos
AR194854A1 (es) Procedimiento para la preparacion de 1,2-difenil-3,6-dioxo-4-hidroxi-5-n-butil-tetrahidropiridazina
AR192762A1 (es) Procedimiento para la preparacion de 1,5-benzodiazepinas